×
Pfizer Revenue 2010-2024 | PFE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pfizer revenue for the twelve months ending December 31, 2024 was
$63.627B
, a
8.77% increase
year-over-year.
Pfizer annual revenue for 2024 was
$63.627B
, a
8.77% increase
from 2023.
Pfizer annual revenue for 2023 was
$58.496B
, a
41.7% decline
from 2022.
Pfizer annual revenue for 2022 was
$100.33B
, a
23.43% increase
from 2021.
View More
Pfizer Revenue 2010-2024 | PFE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pfizer annual revenue for 2024 was
$63.627B
, a
8.77% increase
from 2023.
Pfizer annual revenue for 2023 was
$58.496B
, a
41.7% decline
from 2022.
Pfizer annual revenue for 2022 was
$100.33B
, a
23.43% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$827.9B
Johnson & Johnson (JNJ)
$384.4B
Novo Nordisk (NVO)
$375.8B
AbbVie (ABBV)
$354.6B
Roche Holding AG (RHHBY)
$262.5B
Merck (MRK)
$221.8B
Novartis AG (NVS)
$219.3B
Sanofi (SNY)
$137.4B
Bayer (BAYRY)
$22.6B
Innoviva (INVA)
$1.1B